Boston Collaborative Drug Surveillance Program

The Boston Collaborative Drug Surveillance Program (BCDSP) is an independent, nonprofit research group based in Lexington, Massachusetts. With a team of 8 employees, BCDSP has generated over $2.5 million in revenue. BCDSP specializes in pharmacoepidemiology and disease epidemiology research using electronic health data. They primarily utilize data collected in the United Kingdom and the United States, applying rigorous epidemiological and statistical methods to produce real-world evidence. This evidence supports clinical, regulatory, and pharma decision-making processes. BCDSP's expertise extends to generating real-world evidence for drug development programs, new drug applications, and post-marketing safety surveillance. They also conduct disease epidemiology studies to identify risk factors, describe disease progression and comorbidities, and perform post-authorization safety studies to assess the safety of new treatments. BCDSP's studies encompass a wide range of drugs and diseases. For information on collaborating with BCDSP, visit their website at bcdsp.org.